Heterocyclic anthracycline analogs
US5593970A · kind A · utility
17Cited by
3References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 1994 |
| Grant date | Jan 14, 1997 |
| Priority date | — |
| Expiry date | Jun 20, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H3/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel pyrano heterocyclic anthracycline derivatives are described, which are useful in the treatment of cancer and tumors, such as breast cancer, leukemia, lung cancer, colon cancer, ovarian cancer, renal cancer, and melanoma. As well, these compounds may be used ex vivo for the treatment of cancerous bone marrow before retransplanting said marrow in a patient. Pharmaceutical compositions and methods of preparing the compounds are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.